Search Results - "Tsouderos, Yannis"

Refine Results
  1. 1
  2. 2
  3. 3

    In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation by Baron, Roland, Tsouderos, Yannis

    Published in European journal of pharmacology (16-08-2002)
    “…In order to determine whether 5-[bis(carboxymethyl) amino]-2-carboxy4-cyano-3-thiopheneacetic acid distrontium salt (S12911-2) inhibits bone resorption by…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) by Bruyère, O., Rizzoli, R., Coxam, V., Avouac, B., Chevalier, T., Fabien-Soulé, V., Kanis, J. A., Kaufman, J.-M., Tsouderos, Y., Reginster, J.-Y.

    Published in Osteoporosis international (01-01-2012)
    “…Summary Health claims for food products in Europe are permitted if the nutrient has been shown to have a beneficial nutritional or physiological effect. This…”
    Get full text
    Journal Article Conference Proceeding Web Resource
  6. 6

    An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen‐deficient rats by Marie, Pierre J., Hott, Monique, Modrowski, Dominique, De Pollak, Cinderella, Guillemain, Joel, Deloffre, Pascale, Tsouderos, Yannis

    Published in Journal of bone and mineral research (01-05-1993)
    “…Trabecular bone loss in estrogen deficiency is associated with enhanced bone resorption with a smaller increase in bone formation. We previously reported that…”
    Get full text
    Journal Article
  7. 7
  8. 8

    S 12911‐2 Inhibits Osteoclastic Bone Resorption In Vitro by Takahashi, N, Sasaki, T, Tsouderos, Y, Suda, T

    Published in Journal of bone and mineral research (01-06-2003)
    “…The potential anti‐osteoporotic activity of the strontium compound, S12911, was tested on osteoclast‐like cells and on cultured fetal mouse long bones. From 1…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Mediator: who's to blame? by Waller, Patrick, Evans, Stephen

    Published in The Lancet (British edition) (11-06-2011)
    “…[...] the "estimation" that 500-2000 deaths can be attributed to benfl uorex owing to valvulopathy is pure extrapolation using un justifi ed, hard-line…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration by Boivin, Georges, Deloffre, Pascale, Perrat, Brigitte, Panczer, Gérard, Boudeulle, Micheline, Mauras, Yves, Allain, Pierre, Tsouderos, Yannis, Meunier, Pierre J.

    Published in Journal of bone and mineral research (01-09-1996)
    “…The analysis of the interaction of strontium (Sr) with bone mineral is of interest because a new agent containing Sr (S 12911) has shown positive effects on…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Efficacy and acceptability of intranasal 17 β-oestradiol for menopausal symptoms: randomised dose-response study by Studd, John, Pornel, Bruno, Marton, Istvan, Bringer, Jacques, Varin, Claire, Tsouderos, Yannis, Christiansen, Claus

    Published in The Lancet (British edition) (08-05-1999)
    “…The benefit of oestrogen therapy for menopause symptoms is well recognised. However, the means of delivery currently available have disadvantages, including…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    An Uncoupling Agent Containing Strontium Prevents Bone Loss by Depressing Bone Resorption and Maintaining Bone Formation in Estrogen‐Deficient Rats by Marie, Pierre J., Hott, Monique, Modrowski, Dominique, de Pollak, Cinderella, Guillemain, Joel, Deloffre, Pascale, Tsouderos, Yannis

    Published in Journal of bone and mineral research (01-06-2005)
    “…Trabecular bone loss in estrogen deficiency is associated with enhanced bone resorption with a smaller increase in bone formation. We previously reported that…”
    Get full text
    Journal Article
  19. 19

    Effects of Intranasal 17β-Estradiol on Bone Turnover and Serum Insulin-Like Growth Factor I in Postmenopausal Women by Garnero, Patrick, Tsouderos, Yannis, Marton, Istvan, Pelissier, Clara, Varin, Claire, Delmas, Pierre D

    “…Estrogen therapy, using either oral or transdermal routes, decreases bone turnover and prevents postmenopausal bone loss. It has been suggested that oral and…”
    Get full text
    Journal Article
  20. 20